This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Linda Burkly
Executive Vice President & Chief Scientific Office at Editas Medicine
Speaker

Agenda Sessions

  • Transformative LDL Cholesterol Lowering In Vivo CRISPR Gene Editing Approach for Hyperlipidemia and Atherosclerotic Cardiovascular Disease

    , 8:30am
    View Session

At this event

Prev
Next
David Butler, PhD
Chief Technology Officer
Hongene Biotech Corporation

See Linda at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now